Explore Research
Research Spotlights
Spotlight on Research
- Explore our Spotlights
Our Researchers
Find a researcher
- Search by name or keyword
Enter researcher name
Research Areas
Explore our Colleges
History and cultures
English, Drama and Creative Studies
Languages, Cultures, Art History and Music
Law
Philosophy, Theology and Religion

We explore what it means to be human – in historical and cultural contexts, within ethical and legal norms and through languages and communication.

Explore all Arts and Law Research
Chemical Engineering
Chemistry
Civil Engineering
Computer Science
Electronic, Electrical and Systems Engineering
Energy
Healthcare Technologies Institute
Institute for Gravitational Wave Astronomy
Mathematics
Mechanical Engineering
Metallurgy and Materials
Physics
Quantum Technology Hub
Railways

From atoms to astronomy, computers to cars and robots to robust materials, our goal is to transform our understanding of the world to make life easier, healthier and more sustainable.

Explore all Engineering and Physical Sciences Research
Biosciences
Geography, Earth and Environmental Sciences
Psychology
Sport, Exercise and Rehabilitation Sciences

Across the breadth of life and environmental sciences, we discover, apply and translate science to forge major advances in human and environmental health.

Explore all Life and Environmental Sciences Research
Birmingham Business School
Education
Government
Social Policy

We address the challenges facing society and the economy, from shedding light on the refugee crisis, to character education in schools, through to developing leaders in the NHS.

Explore all Social Sciences Research
PhDs
Institutes
Research News

Current Collaborators

Open to recruitment

Treatment Arm I: Odronextamab (Bispecific antibody), Regeneron Pharmaceuticals Inc.
Treatment Arm II: Loncastuximab tesirine (Antibody Drug Conjugate) with standard chemotherapy, ADC Therapeutics SA

Under development

Treatment Arm III: Chimeric antigen receptor (CAR) T-cells, TBC
Treatment Arm IV: Golcadomide (CELMoD™ agent) with Rituximab, Bristol Myers Squibb